• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Childhood Fevers Heat Up ADHD Risk
Research Update

Childhood Fevers Heat Up ADHD Risk

July 1, 2025
Jessica Giddens, DNP
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Jessica Giddens, DNP. Dr. Giddens has no financial relationships with companies related to this material.

Getting your Trinity Audio player ready...

REVIEW OF: Israel A et al, J Atten Disord 2024;28(5):677–685

STUDY TYPE: Population-based case-control study

Some research studies have associated inflammation with ADHD. This new study provides compelling data implicating common childhood fevers as an ADHD risk factor. 

Researchers relied on a comprehensive computerized database to analyze data on 18,558 children with ADHD and 37,116 matched controls without ADHD (ages 5–18). The two groups were matched by age, gender, birth year and quarter, socioeconomic status, ethnicity, and region to prevent variables other than fever from affecting the findings. Data on febrile episodes during the first 4 years of life were collected from medical records, focusing on the number of times (0–3+ measurements) when body temperature exceeded 5 defined fever thresholds (99.5°F [37.5°C] to 103.5°F [39.5°C]).

Kids diagnosed with ADHD had significantly more febrile episodes in their early years than their non-ADHD peers across all temperature thresholds (p<.001). The relationship wasn’t subtle—how often kids had fevers, and how high those fevers ran, correlated with increased ADHD risk. Children who had no documented fevers above 99.5°F actually showed reduced ADHD rates (odds ratio [OR] = 0.834). Kids who had 3+ episodes of fever above 103.5°F had more than double the odds of developing ADHD (OR = 2.135).

CARLAT TAKE
This study found a dose-related correlation between both fever frequency and intensity in early childhood and subsequent ADHD diagnosis, although it is possible that a separate factor drives the risk for both fever and ADHD. Young children are prone to developing fevers from community-acquired infections, from vaccines that can prevent even higher fevers, and even from teething. We would like to see research studying whether fever management can reduce ADHD outcomes. For now, a history of frequent early childhood illnesses might help complete the clinical picture for our patients with ADHD.

Child Psychiatry
KEYWORDS ADHD diagnosis ADHD risk childhood fevers early childhood fever frequency fever intensity inflammation population study
    Jessica Giddens, DNP

    More from this author
    www.thecarlatreport.com
    Issue Date: July 1, 2025
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, ADHD in Children and Adolescents, CCPR, July/August/September 2025
    ADHD Update 2025: New Treatments and Current Approaches for Co-Occurring Conditions
    Navigating ADHD Into Adulthood
    Nutritional Psychiatry for Children and Teens
    Supporting Better Self-Esteem in ADHD
    Childhood Fevers Heat Up ADHD Risk
    Omega-3 Supplementation Reduces Schizotypal Traits in Children
    Beyond “Yes”: Understanding Sexual Consent on College Campuses
    CME Post-Test, ADHD in Children and Adolescents, CCPR, July/August/September 2025
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2669706505.jpg
      General Psychiatry

      A New Ketamine

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.